期刊文献+

解毒护肝饮药物血清对异烟肼致HepG2坏死和凋亡的干预 被引量:1

Effect of Jiedu Hugan Decoction containing serum on the death and apoptosis of HepG2 which were damaged by isoniazid
下载PDF
导出
摘要 目的 观察解毒护肝饮药物血清对异烟肼致人肝癌细胞株(human hepatocellular carcinoma cell lines,HepG2)病变的干预,并分析其机制。方法 制备解毒护肝饮和甘草酸二铵的药物血清,建立异烟肼致HepG2细胞损伤模型,以解毒护肝饮和甘草酸二铵药物血清加入HepG2培养液,观察对HepG2坏死和凋亡的干预,以及对HepG2 Fas/FasL表达的影响,以评价解毒护肝饮的疗效机制。结果 解毒护肝饮药物血清对异烟肼致HepG2损伤有明显抑制作用,可以减少HepG2细胞凋亡和坏死,并减少其Fas/FasL表达,效果优于甘草酸二铵胶囊组。结论 以清热利湿解毒兼养阴化瘀为治法的解毒护肝饮有确切的减少异烟肼致HepG2坏死和凋亡的作用,其抗细胞凋亡作用与减少HepG2的Fas/FasL的表达有关。 ObjectiveTo observe the effect of Jiedu Hugan Decoction containing serum on HepG2 damaged by isoniazid,and reveal the mechanism of it.MethodsEstablish iv votro HepG2 cell damaged by isoniazid culture experiment model.The serum was collected from the rats using Jiedu Hugan Decoction and Gancaosuaneran and incubated with the HepG2 model.After 24 hours,observe the death and apoptosis of HepG2.And the expressions of Fas/FasL were measured by flow cytometry.ResultsCulture experiment model of iv votro HepG2 cell damaged by isoniazid was established successfully.Jiedu Hugan Decoction containing serum significantly inhibited apoptosis and necrosis of the HepG2 cells and the expression of Fas/FasL.The curative effect of this is better than control group which were given Gancaosuaneran decoction containing serum.ConclusionJiedu Hugan Decoction according to qingre lishi jiedu can evidently reduce the hepatitis by decrease the expression of the factor associated with apoptosis.So it can improve the syndromes and experimental index of hepatitis induced by anti-tubercular drug.
出处 《环球中医药》 CAS 2012年第4期259-262,共4页 Global Traditional Chinese Medicine
基金 财政部 国家中医药管理局2009年中医药行业科研专项(200907001-1)
关键词 解毒护肝饮 药物性肝炎 异烟肼 药物血清 凋亡 人肝癌细胞株 体外培养 FAS/FASL Jiedu Hugan Decoction Drug hepatitis Isoniazid Drug containing serum Apoptosis HepG2 Iv votro Fas/FasL
  • 相关文献

参考文献11

  • 1宋卫国.柴茯调脂口服液对高血脂大鼠模型的影响[J].时珍国医国药,2009,20(7):1755-1756. 被引量:4
  • 2Schwab CE,Tuschl H.In vitro studies on the toxicity of isoniazid in different cell lines[J].Hum Exp Toxicol,2003,22(11):607-615.
  • 3Cho HJ,Koh WJ,Ryu YJ,et al.Genetic polymorphisms of NAT2and CYP2E1associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis[J].Tuberculosis(Edinb),2007,87(6):551-556.
  • 4Huang YS,Chern HD,Su WJ,et al.Polymorphism of the N-acetyltransferase2gene as a susceptibility risk factor for antitu-berculosis drug-induced hepatitis[J].Hepatology,2002,35(4):883-889.
  • 5沈冲,徐小梅,孟琴,苏关关,赵年丰.原代肝细胞体外培养用于利福平和异烟肼肝毒性的研究[J].中国药科大学学报,2005,36(3):250-253. 被引量:9
  • 6Sarich TC,ZHOU T,Adams SP,et al.A model of isoniazid-in-duced hepatotoxicity in rabbits[J].J Pharmacol Toxicol Methods,1995,34(2):109-116.
  • 7Nicod L,Viollon C,Regnier A,et al.Rifampicin and isoniazid in-crease acetaminophen and isoniazid cytotoxicity in human HepG2hepatoma cells[J].Hum Exp Toxicol,1997,16(1):28-34.
  • 8Neuman MG,Koren G,Tiribelli C.In vitro assessment of ethnol-induced hepatotoxicity on HepG2cell line[J].Biochem Biophys Res Commun,1993,197(2):932-941.
  • 9Shear NH,Malkiewicz IM,Klein D,et al.Acetaminophen-induced toxicity to human epidermoid celil line A431and hepatoblastoma cell line HegG2in vitro,is diminished by silymarin[J].Skin Pharmaco1,1995,8(6):279-291.
  • 10Coroneos E,Sim E.Arylamine N-acetyltransferase activity in hum-an cultures cell lines[J].Biochem J,1993,294(Pt2):481-486.

二级参考文献11

  • 1Grosset J, Leventis S. Adverse effects of rifampicin [J]. Rev Infect Dis, 1983,5:440-446.
  • 2Snider DE, Cams GJ. Isoniazid associated hepatitis deaths:a review of available information[J]. Am Rev Respir Dis, 1992,145:494-497.
  • 3Steele MA, Burk RF, Desprez RIM. Toxic hepatitis with isoniazid and rifampicin[J]. A meta-analysis Chest, 1991,99:465-471.
  • 4Mookan P, Rangasamy A, Thiruvengadam D. Protective effect of Hemidesums indicus against rifampicin and isoniazid-induced hepatotoxicity in rats[J]. Fitoterapia, 2000,71:55-59.
  • 5Nicod L, Viollon C, Regnier A, et al. Rifampicin and isoniazid increase acetaminophen and isoniazid cytotoxicity in human HepG2 hepatoma cells [J]. Hum Exp Taxicol, 1997,16(1):28-34.
  • 6Attri S, Rana SV, Vaiphei K, et al. Isoniazid and rifampicin-induced oxidative hepatic injury-protection by N-acetylcysteine[J]. Hum Exp Toxicol, 2000,19(9):517-522.
  • 7Troy C, Ting Z, Stephen P, et al. A model of isoniazid-induced hepatotoxicity in rabbits[J]. Pharmacol Toxicol Methods, 1995,34:109-116.
  • 8Seglen Per O. Preparation of isolated rat liver cells[J]. Methods Cell Biol, 1976,13:30-83.
  • 9Pessayre D, Mazel P. Induction and inhibition of hepatic drug metabolizing enzymes by rifampin[J]. Chem Pharmacol, 1976,25:943.
  • 10Thomas BH, Solomonraj G. Drug interactions with isoniazid metabolism in rats[J]. J Pharm Sci, 1977,66(9):1322-1326.

共引文献20

同被引文献8

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部